James Watters
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- Colorectal Cancer Treatments and Studies
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 5
- Oncology 12
- Cancer-related Molecular Pathways 5
- Cancer Treatment and Pharmacology 3
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- Howard L. McLeod (12 shared papers)William F. Dietrich (3 shared papers)Tim Demuth (4 shared papers)Andrey Loboda (6 shared papers)Pearl S. Huang (4 shared papers)Michael Nebozhyn (3 shared papers)Hongyue Dai (3 shared papers)Aldi T. Kraja (1 shared paper)
- Journals
- Cancer Research (7 papers)Journal of Clinical Oncology (2 papers)Clinical Cancer Research (2 papers)BMC Medical Genomics (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- United StatesFranceNetherlands
In The Last Decade
James Watters
40 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 103
- Oncology 695
- Cancer Research 336
- Molecular Biology 1.1k
- Pharmacology 89
- Biotechnology 84
Countries citing papers authored by James Watters
This map shows the geographic impact of James Watters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Watters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Watters more than expected).
Fields of papers citing papers by James Watters
This network shows the impact of papers produced by James Watters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Watters. The network helps show where James Watters may publish in the future.
Co-authors
The 25 scholars most cited alongside James Watters, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 255 | |
| 2 | 2011 | 236 | |
| 3 | 2011 | 215 | |
| 4 | 2009 | 140 | |
| 5 | 2009 | 122 | |
| 6 | 2004 | 111 | |
| 7 | 2010 | 107 | |
| 8 | 2003 | 105 | |
| 9 | 2016 | 78 | |
| 10 | 2007 | 72 | |
| 11 | 2001 | 65 | |
| 12 | 1998 | 64 | |
| 13 | 2015 | 57 | |
| 14 | 2004 | 41 | |
| 15 | 2009 | 31 | |
| 16 | 2007 | 30 | |
| 17 | 2017 | 28 | |
| 18 | 2003 | 27 | |
| 19 | 2006 | 24 | |
| 20 | 2001 | 23 |
About James Watters
James Watters is a scholar working on Molecular Biology, Oncology, Cancer Research, Pharmacology and Pulmonary and Respiratory Medicine, having authored 40 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), Pharmacogenetics and Drug Metabolism (8 papers), Cancer-related Molecular Pathways (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Lung Cancer Treatments and Mutations (4 papers), BRCA gene mutations in cancer (3 papers), Cancer Treatment and Pharmacology (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Oncology (695 citations), Cancer Research (336 citations), Molecular Biology (1.1k citations), Pharmacology (89 citations) and Biotechnology (84 citations). James Watters has collaborated with scholars based in United States, France and Netherlands. Frequent co-authors include Howard L. McLeod, William F. Dietrich, Tim Demuth, Andrey Loboda, Pearl S. Huang, Michael Nebozhyn, Hongyue Dai, Aldi T. Kraja, Michael A. Province and Timothy J. Yeatman. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Clinical Cancer Research, BMC Medical Genomics and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.